On Monday, Moderna Inc (NASDAQ: MRNA) opened higher 2.79% from the last session, before settling in for the closing price of $43.06. Price fluctuations for MRNA have ranged from $35.80 to $170.47 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 662.08% over the last five years. Company’s average yearly earnings per share was noted 23.81% at the time writing. With a float of $343.15 million, this company’s outstanding shares have now reached $385.00 million.
The firm has a total of 5600 workers. Let’s measure their productivity. In terms of profitability, gross margin is 65.9%, operating margin of -53.05%, and the pretax margin is -46.36%.
Moderna Inc (MRNA) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Moderna Inc is 10.83%, while institutional ownership is 67.51%. The most recent insider transaction that took place on Nov 29 ’24, was worth 60,761. In this transaction Chief Financial Officer of this company sold 1,420 shares at a rate of $42.79, taking the stock ownership to the 11,066 shares. Before that another transaction happened on Nov 29 ’24, when Company’s Chief Legal Officer sold 1,418 for $42.79, making the entire transaction worth $60,675. This insider now owns 19,717 shares in total.
Moderna Inc (MRNA) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 23.81% per share during the next fiscal year.
Moderna Inc (NASDAQ: MRNA) Trading Performance Indicators
Check out the current performance indicators for Moderna Inc (MRNA). In the past quarter, the stock posted a quick ratio of 4.20. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.82, a number that is poised to hit -2.76 in the next quarter and is forecasted to reach -8.98 in one year’s time.
Technical Analysis of Moderna Inc (MRNA)
Analysing the last 5-days average volume posted by the [Moderna Inc, MRNA], we can find that recorded value of 7.72 million was better than the volume posted last year of 4.9 million. As of the previous 9 days, the stock’s Stochastic %D was 73.74%. Additionally, its Average True Range was 2.82.
During the past 100 days, Moderna Inc’s (MRNA) raw stochastic average was set at 9.04%, which indicates a significant decrease from 80.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 75.71% in the past 14 days, which was higher than the 63.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $52.39, while its 200-day Moving Average is $94.99. Now, the first resistance to watch is $45.26. This is followed by the second major resistance level at $46.25. The third major resistance level sits at $47.84. If the price goes on to break the first support level at $42.67, it is likely to go to the next support level at $41.07. Should the price break the second support level, the third support level stands at $40.08.
Moderna Inc (NASDAQ: MRNA) Key Stats
There are currently 384,818K shares outstanding in the company with a market cap of 16.90 billion. Presently, the company’s annual sales total 6,848 M according to its annual income of -4,714 M. Last quarter, the company’s sales amounted to 1,862 M and its income totaled 13,000 K.
